MCID: USH037
MIFTS: 44

Usher Syndrome, Type Iia

Categories: Genetic diseases, Rare diseases, Eye diseases, Ear diseases, Fetal diseases

Aliases & Classifications for Usher Syndrome, Type Iia

MalaCards integrated aliases for Usher Syndrome, Type Iia:

Name: Usher Syndrome, Type Iia 57 73
Usher Syndrome, Type 2a 57 76 29 13 6 40
Ush2a 57 12 53 75
Usher Syndrome Type 2a 12 53 15
Usher Syndrome Type Iia 12 75
Retinal Disease in Usher Syndrome Type Iia, Modifier of 57
Usher's Syndrome Type 2a 75
Usher Syndrome 2a 75
Ushiia 75
Ush2 53
Us2 53

Characteristics:

OMIM:

57
Inheritance:
autosomal recessive

Miscellaneous:
accounts for 70% of all usher syndrome patients


HPO:

32
usher syndrome, type iia:
Inheritance autosomal recessive inheritance


Classifications:



External Ids:

OMIM 57 276901
Disease Ontology 12 DOID:0110838
ICD10 33 H35.5
MedGen 42 C1848634
MeSH 44 D052245
SNOMED-CT via HPO 69 258211005 28835009 700453005
UMLS 73 C1848634

Summaries for Usher Syndrome, Type Iia

NIH Rare Diseases : 53 Usher syndrome type 2A is a genetic condition characterized by hearing loss from birth and progressive vision loss that begins in adolescence or adulthood. Vision loss is due to retinitis pigmentosa. Night vision loss begins first, followed by blind spots that develop in the side (peripheral) vision. Over time, these blind spots enlarge and merge to produce tunnel vision. In some cases, vision is further impaired by clouding of the front surface of the eye (cataracts). Hearing loss ranges from mild to severe and mainly affects high tones. The degree of hearing loss varies within and among families with this condition. Unlike other forms of Usher syndrome, people with type 2A do not have difficulties with balance caused by inner ear problems. Usher syndrome type 2A is caused by mutations the USH2A gene and is inherited in an autosomal recessive manner.

MalaCards based summary : Usher Syndrome, Type Iia, also known as usher syndrome, type 2a, is related to usher syndrome, type iid and usher syndrome. An important gene associated with Usher Syndrome, Type Iia is USH2A (Usherin), and among its related pathways/superpathways is Colorectal Cancer Metastasis. Affiliated tissues include retina and eye, and related phenotypes are rod-cone dystrophy and congenital sensorineural hearing impairment

OMIM : 57 Usher syndrome is a clinically and genetically heterogeneous autosomal recessive disorder characterized by sensorineural hearing deficiencies at birth and later development of progressive retinitis pigmentosa (RP). It is the most frequent cause of combined deafness and blindness in adults and affects 3 to 6% of children born with hearing impairment. In brief, patients with Usher syndrome type II have mild hearing impairment with normal vestibular responses. Type II is the most common of the 3 Usher syndromes (Eudy et al., 1998). See 276900 for clinical characterization of Usher syndrome types I, II, and III. (276901)

UniProtKB/Swiss-Prot : 75 Usher syndrome 2A: USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH2 is characterized by congenital mild hearing impairment with normal vestibular responses.

Disease Ontology : 12 An Usher syndrome type 2 characterized by moderate to severe sensorineural hearing loss, mainly affecting perception of high frequency sounds and progressive retinitis pigmentosa that has material basis in homozygous or compound heterozygous mutation in the USH2A gene on chromosome 1q41.

Wikipedia : 76 Usher syndrome, also known as Hallgren syndrome, Usher-Hallgren syndrome, retinitis pigmentosa-dysacusis... more...

Related Diseases for Usher Syndrome, Type Iia

Diseases in the Usher Syndrome family:

Usher Syndrome, Type I Usher Syndrome, Type Iia
Usher Syndrome, Type Iiia Usher Syndrome, Type Ic
Usher Syndrome, Type Id Usher Syndrome, Type if
Usher Syndrome, Type Iic Usher Syndrome, Type Ig
Usher Syndrome, Type Iid Usher Syndrome, Type Ih
Usher Syndrome, Type Iiib Usher Syndrome, Type Ij
Usher Syndrome, Type Ik Usher Syndrome Type 2
Usher Syndrome, Type 2b

Diseases related to Usher Syndrome, Type Iia via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 21)
# Related Disease Score Top Affiliating Genes
1 usher syndrome, type iid 31.9 PDZD7 USH1C USH2A WHRN
2 usher syndrome 29.9 PDZD7 USH1C USH2A WHRN
3 retinitis pigmentosa 27.9 PDZD7 RD3 USH1C USH2A WHRN
4 retinitis pigmentosa 39 11.7
5 retinitis pigmentosa-deafness syndrome 10.5
6 deafness, autosomal recessive 6 10.2 GSK3B USH2A
7 usher syndrome, type id 10.2 USH1C USH2A
8 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.1
9 deafness, autosomal dominant 44 10.0 EGF EYA4
10 herpes simplex 10.0
11 leber congenital amaurosis 4 9.9
12 retinitis 9.9
13 nonsyndromic retinitis pigmentosa 9.9
14 sensorineural hearing loss 9.9 EYA4 USH2A WHRN
15 usher syndrome, type iiia 9.9 USH1C USH2A
16 deafness, autosomal dominant 13 9.8 EYA4 USH2A
17 usher syndrome, type iic 9.5 PDZD7 USH1C USH2A WHRN
18 usher syndrome, type i 9.4 GSK3B USH1C USH2A WHRN
19 breast cyst 9.4 EGF TGFB2
20 usher syndrome type 2 9.1 GSK3B PDZD7 USH1C USH2A WHRN
21 nonsyndromic deafness 9.0 EYA4 PDZD7 USH1C USH2A WHRN

Graphical network of the top 20 diseases related to Usher Syndrome, Type Iia:



Diseases related to Usher Syndrome, Type Iia

Symptoms & Phenotypes for Usher Syndrome, Type Iia

Symptoms via clinical synopsis from OMIM:

57
Head And Neck Ears:
hearing loss, congenital, sensorineural, moderate-severe
normal vestibular response

Head And Neck Eyes:
retinitis pigmentosa, progressive


Clinical features from OMIM:

276901

Human phenotypes related to Usher Syndrome, Type Iia:

32
# Description HPO Frequency HPO Source Accession
1 rod-cone dystrophy 32 HP:0000510
2 congenital sensorineural hearing impairment 32 HP:0008527

MGI Mouse Phenotypes related to Usher Syndrome, Type Iia:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 9.86 EGF ESRRG EYA4 GSK3B HLX TGFB2
2 digestive/alimentary MP:0005381 9.8 EGF EYA4 GSK3B HLX TGFB2 USH1C
3 hearing/vestibular/ear MP:0005377 9.7 ESRRG EYA4 PDZD7 TGFB2 USH1C USH2A
4 nervous system MP:0003631 9.56 GSK3B HLX PDZD7 RD3 TGFB2 USH1C
5 vision/eye MP:0005391 9.17 EGF PDZD7 RD3 TGFB2 USH1C USH2A

Drugs & Therapeutics for Usher Syndrome, Type Iia

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Rate of Progression in USH2A Related Retinal Degeneration Recruiting NCT03146078

Search NIH Clinical Center for Usher Syndrome, Type Iia

Genetic Tests for Usher Syndrome, Type Iia

Genetic tests related to Usher Syndrome, Type Iia:

# Genetic test Affiliating Genes
1 Usher Syndrome, Type 2a 29 PDZD7 USH2A

Anatomical Context for Usher Syndrome, Type Iia

MalaCards organs/tissues related to Usher Syndrome, Type Iia:

41
Retina, Eye

Publications for Usher Syndrome, Type Iia

Articles related to Usher Syndrome, Type Iia:

(show all 20)
# Title Authors Year
1
Cochlear Implantation in Patients With Usher Syndrome Type IIa Increases Performance and Quality of Life. ( 28498263 )
2017
2
Visual Prognosis in USH2A-Associated Retinitis Pigmentosa Is Worse for Patients with Usher Syndrome Type IIa Than for Those with Nonsyndromic Retinitis Pigmentosa. ( 26927203 )
2016
3
Hearing aid fitting for visual and hearing impaired patients with Usher Syndrome type IIa. ( 27759911 )
2016
4
A combination of two truncating mutations in USH2A causes more severe and progressive hearing impairment in Usher syndrome type IIa. ( 27318125 )
2016
5
Expressivity of hearing loss in cases with Usher syndrome type IIA. ( 24160897 )
2013
6
Usherin, the defective protein in Usher syndrome type IIA, is likely to be a component of interstereocilia ankle links in the inner ear sensory cells. ( 16301217 )
2005
7
Audiological findings in Usher syndrome types IIa and II (non-IIa). ( 15198377 )
2004
8
Immunohistochemistry and reverse transcriptase-polymerase chain reaction as methods for diagnostic determination of usher syndrome type IIa. ( 15235367 )
2004
9
Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II. ( 15015129 )
2004
10
Identification of the mouse and rat orthologs of the gene mutated in Usher syndrome type IIA and the cellular source of USH2A mRNA in retina, a target tissue of the disease. ( 12160733 )
2002
11
Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. ( 10729113 )
2000
12
A mutation (2314delG) in the Usher syndrome type IIA gene: high prevalence and phenotypic variation. ( 10090909 )
1999
13
Semen analysis in the Usher syndrome type 2A. ( 10325550 )
1999
14
Mutation of a gene encoding a protein with extracellular matrix motifs in Usher syndrome type IIa. ( 9624053 )
1998
15
Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41. ( 9676434 )
1998
16
Hearing loss in the RBF/DnJ mouse, a proposed animal model of Usher syndrome type IIa. ( 9367224 )
1997
17
The construction of a yeast artificial chromosome (YAC) contig in the vicinity of the Usher syndrome type IIa (USH2A) gene in 1q41. ( 8661107 )
1996
18
The Usher syndrome type 2A: clinical findings in obligate carriers. ( 7782174 )
1995
19
Ophthalmologic findings in Usher syndrome type 2A. ( 8749051 )
1995
20
Gene mapping of Usher syndrome type IIa: localization of the gene to a 2.1-cM segment on chromosome 1q41. ( 7825581 )
1995

Variations for Usher Syndrome, Type Iia

UniProtKB/Swiss-Prot genetic disease variations for Usher Syndrome, Type Iia:

75 (show top 50) (show all 59)
# Symbol AA change Variation ID SNP ID
1 USH2A p.Cys163Tyr VAR_025761
2 USH2A p.Val218Glu VAR_025762 rs397518026
3 USH2A p.Cys319Tyr VAR_025764 rs121912599
4 USH2A p.Arg334Trp VAR_025765 rs397517963
5 USH2A p.Asn346His VAR_025766 rs369522997
6 USH2A p.Cys419Phe VAR_025767 rs121912600
7 USH2A p.Cys536Arg VAR_025769 rs111033273
8 USH2A p.Leu555Val VAR_025770 rs35818432
9 USH2A p.His610Pro VAR_025771
10 USH2A p.Cys759Phe VAR_025775 rs80338902
11 USH2A p.Pro761Arg VAR_025776
12 USH2A p.Thr1515Met VAR_025779 rs373599651
13 USH2A p.Arg4115Cys VAR_025780 rs111033275
14 USH2A p.Thr4425Met VAR_025781 rs201238640
15 USH2A p.Leu280Phe VAR_054558
16 USH2A p.Glu284Lys VAR_054559
17 USH2A p.Arg303Cys VAR_054560
18 USH2A p.Arg303Ser VAR_054561 rs748465849
19 USH2A p.Arg334Gln VAR_054563 rs758303489
20 USH2A p.Thr352Ile VAR_054564 rs780308389
21 USH2A p.Asn357Thr VAR_054565
22 USH2A p.Pro1212Leu VAR_054579
23 USH2A p.Val1833Glu VAR_054584
24 USH2A p.Ala2249Asp VAR_054588
25 USH2A p.Arg2354His VAR_054591 rs201386640
26 USH2A p.Ala2795Ser VAR_054593
27 USH2A p.Cys3251Arg VAR_054598 rs527236118
28 USH2A p.Cys3267Arg VAR_054599 rs111033263
29 USH2A p.Cys3282Arg VAR_054600
30 USH2A p.Pro3504Thr VAR_054602
31 USH2A p.Trp3521Arg VAR_054603 rs111033264
32 USH2A p.Thr3571Met VAR_054604 rs202175091
33 USH2A p.Gly3895Glu VAR_054608
34 USH2A p.Thr3976Met VAR_054609 rs142381713
35 USH2A p.Ser4054Ile VAR_054610
36 USH2A p.Pro4232Arg VAR_054611 rs745371873
37 USH2A p.Thr4337Met VAR_054612 rs527236137
38 USH2A p.Thr4439Ile VAR_054614 rs753330544
39 USH2A p.Tyr4487Cys VAR_054615 rs768893227
40 USH2A p.Gln4592His VAR_054616
41 USH2A p.Leu4795Arg VAR_054618 rs199851839
42 USH2A p.Pro4818Leu VAR_054619 rs143344549
43 USH2A p.Gly44Arg VAR_071996
44 USH2A p.Ser180Pro VAR_071997
45 USH2A p.Val382Met VAR_071998 rs750651679
46 USH2A p.Cys691Tyr VAR_071999
47 USH2A p.Gly1734Arg VAR_072003
48 USH2A p.Arg1777Trp VAR_072004 rs770329105
49 USH2A p.Gly1840Val VAR_072006
50 USH2A p.Pro1843Leu VAR_072007 rs200209833

ClinVar genetic disease variations for Usher Syndrome, Type Iia:

6
(show top 50) (show all 301)
# Gene Variation Type Significance SNP ID Assembly Location
1 USH2A NM_206933.2(USH2A): c.2299delG (p.Glu767Serfs) deletion Pathogenic/Likely pathogenic rs80338903 GRCh37 Chromosome 1, 216420437: 216420437
2 USH2A NM_206933.2(USH2A): c.2299delG (p.Glu767Serfs) deletion Pathogenic/Likely pathogenic rs80338903 GRCh38 Chromosome 1, 216247095: 216247095
3 USH2A NM_206933.2(USH2A): c.2898delG (p.Thr967Leufs) deletion Pathogenic rs397518008 GRCh37 Chromosome 1, 216405390: 216405390
4 USH2A NM_206933.2(USH2A): c.2898delG (p.Thr967Leufs) deletion Pathogenic rs397518008 GRCh38 Chromosome 1, 216232048: 216232048
5 USH2A NM_007123.5(USH2A): c.4338_4339delCT (p.Cys1447Glnfs) deletion Pathogenic rs111033367 GRCh37 Chromosome 1, 216363622: 216363623
6 USH2A NM_007123.5(USH2A): c.4338_4339delCT (p.Cys1447Glnfs) deletion Pathogenic rs111033367 GRCh38 Chromosome 1, 216190280: 216190281
7 USH2A NM_206933.2(USH2A): c.779T> G (p.Leu260Ter) single nucleotide variant Pathogenic rs121912598 GRCh37 Chromosome 1, 216538300: 216538300
8 USH2A NM_206933.2(USH2A): c.779T> G (p.Leu260Ter) single nucleotide variant Pathogenic rs121912598 GRCh38 Chromosome 1, 216364958: 216364958
9 USH2A NM_206933.2(USH2A): c.11864G> A (p.Trp3955Ter) single nucleotide variant Pathogenic rs111033364 GRCh37 Chromosome 1, 215901574: 215901574
10 USH2A NM_206933.2(USH2A): c.11864G> A (p.Trp3955Ter) single nucleotide variant Pathogenic rs111033364 GRCh38 Chromosome 1, 215728232: 215728232
11 USH2A NM_206933.2(USH2A): c.949C> A (p.Arg317=) single nucleotide variant Pathogenic rs111033272 GRCh37 Chromosome 1, 216498841: 216498841
12 USH2A NM_206933.2(USH2A): c.949C> A (p.Arg317=) single nucleotide variant Pathogenic rs111033272 GRCh38 Chromosome 1, 216325499: 216325499
13 USH2A NM_206933.2(USH2A): c.1256G> T (p.Cys419Phe) single nucleotide variant Pathogenic rs121912600 GRCh37 Chromosome 1, 216497582: 216497582
14 USH2A NM_206933.2(USH2A): c.1256G> T (p.Cys419Phe) single nucleotide variant Pathogenic rs121912600 GRCh38 Chromosome 1, 216324240: 216324240
15 USH2A NM_206933.2(USH2A): c.240_241insGATC (p.Gln81Aspfs) insertion Pathogenic rs587776538 GRCh37 Chromosome 1, 216595438: 216595439
16 USH2A NM_206933.2(USH2A): c.240_241insGATC (p.Gln81Aspfs) insertion Pathogenic rs587776538 GRCh38 Chromosome 1, 216422096: 216422097
17 USH2A NM_206933.2(USH2A): c.2209C> T (p.Arg737Ter) single nucleotide variant Pathogenic rs111033334 GRCh37 Chromosome 1, 216420527: 216420527
18 USH2A NM_206933.2(USH2A): c.2209C> T (p.Arg737Ter) single nucleotide variant Pathogenic rs111033334 GRCh38 Chromosome 1, 216247185: 216247185
19 USH2A NM_206933.2(USH2A): c.7595-2144A> G single nucleotide variant Pathogenic/Likely pathogenic rs786200928 GRCh37 Chromosome 1, 216064540: 216064540
20 USH2A NM_206933.2(USH2A): c.7595-2144A> G single nucleotide variant Pathogenic/Likely pathogenic rs786200928 GRCh38 Chromosome 1, 215891198: 215891198
21 USH2A NM_206933.2(USH2A): c.3129dupT (p.Val1044Cysfs) duplication Pathogenic rs786205115 GRCh38 Chromosome 1, 216217415: 216217415
22 USH2A NM_206933.2(USH2A): c.3129dupT (p.Val1044Cysfs) duplication Pathogenic rs786205115 GRCh37 Chromosome 1, 216390757: 216390757
23 USH2A NM_206933.2(USH2A): c.8890dupT (p.Trp2964Leufs) duplication Pathogenic rs786205116 GRCh37 Chromosome 1, 216019331: 216019331
24 USH2A NM_206933.2(USH2A): c.8890dupT (p.Trp2964Leufs) duplication Pathogenic rs786205116 GRCh38 Chromosome 1, 215845989: 215845989
25 PDZD7 NM_001195263.1(PDZD7): c.166dupC (p.Arg56Profs) duplication Pathogenic,risk factor rs587776894 GRCh37 Chromosome 10, 102789811: 102789811
26 PDZD7 NM_001195263.1(PDZD7): c.166dupC (p.Arg56Profs) duplication Pathogenic,risk factor rs587776894 GRCh38 Chromosome 10, 101030054: 101030054
27 USH2A NM_206933.2(USH2A): c.10712C> T (p.Thr3571Met) single nucleotide variant Likely pathogenic rs202175091 GRCh37 Chromosome 1, 215955412: 215955412
28 USH2A NM_206933.2(USH2A): c.10712C> T (p.Thr3571Met) single nucleotide variant Likely pathogenic rs202175091 GRCh38 Chromosome 1, 215782070: 215782070
29 USH2A NM_206933.2(USH2A): c.10724G> A (p.Cys3575Tyr) single nucleotide variant Likely pathogenic rs111033265 GRCh37 Chromosome 1, 215955400: 215955400
30 USH2A NM_206933.2(USH2A): c.11231+1G> T single nucleotide variant Likely pathogenic rs111033382 GRCh37 Chromosome 1, 215933001: 215933001
31 USH2A NM_206933.2(USH2A): c.11231+1G> T single nucleotide variant Likely pathogenic rs111033382 GRCh38 Chromosome 1, 215759659: 215759659
32 USH2A NM_206933.2(USH2A): c.1143+1G> A single nucleotide variant Pathogenic rs397517974 GRCh37 Chromosome 1, 216498646: 216498646
33 USH2A NM_206933.2(USH2A): c.1143+1G> A single nucleotide variant Pathogenic rs397517974 GRCh38 Chromosome 1, 216325304: 216325304
34 USH2A NM_206933.2(USH2A): c.12714T> G (p.Tyr4238Ter) single nucleotide variant Pathogenic rs397517981 GRCh38 Chromosome 1, 215675197: 215675197
35 USH2A NM_206933.2(USH2A): c.12739G> A (p.Gly4247Arg) single nucleotide variant Likely pathogenic rs397517982 GRCh37 Chromosome 1, 215848514: 215848514
36 USH2A NM_206933.2(USH2A): c.12739G> A (p.Gly4247Arg) single nucleotide variant Likely pathogenic rs397517982 GRCh38 Chromosome 1, 215675172: 215675172
37 USH2A NM_206933.2(USH2A): c.12868C> T (p.Gln4290Ter) single nucleotide variant Pathogenic rs397517983 GRCh38 Chromosome 1, 215675043: 215675043
38 USH2A NM_206933.2(USH2A): c.14911C> T (p.Arg4971Ter) single nucleotide variant Pathogenic rs397517994 GRCh37 Chromosome 1, 215813957: 215813957
39 USH2A NM_206933.2(USH2A): c.11411delC (p.Pro3804Leufs) deletion Pathogenic rs397517973 GRCh37 Chromosome 1, 215916656: 215916656
40 USH2A NM_206933.2(USH2A): c.11411delC (p.Pro3804Leufs) deletion Pathogenic rs397517973 GRCh38 Chromosome 1, 215743314: 215743314
41 USH2A NM_206933.2(USH2A): c.1227G> C (p.Trp409Cys) single nucleotide variant Likely pathogenic rs397517979 GRCh37 Chromosome 1, 216497611: 216497611
42 USH2A NM_206933.2(USH2A): c.1227G> C (p.Trp409Cys) single nucleotide variant Likely pathogenic rs397517979 GRCh38 Chromosome 1, 216324269: 216324269
43 USH2A NM_206933.2(USH2A): c.12294+1G> C single nucleotide variant Likely pathogenic rs111033526 GRCh37 Chromosome 1, 215853490: 215853490
44 USH2A NM_206933.2(USH2A): c.12294+1G> C single nucleotide variant Likely pathogenic rs111033526 GRCh38 Chromosome 1, 215680148: 215680148
45 USH2A NM_206933.2(USH2A): c.10724G> A (p.Cys3575Tyr) single nucleotide variant Likely pathogenic rs111033265 GRCh38 Chromosome 1, 215782058: 215782058
46 USH2A NM_206933.2(USH2A): c.10759C> T (p.Gln3587Ter) single nucleotide variant Pathogenic/Likely pathogenic rs111033418 GRCh37 Chromosome 1, 215953365: 215953365
47 USH2A NM_206933.2(USH2A): c.12868C> T (p.Gln4290Ter) single nucleotide variant Pathogenic rs397517983 GRCh37 Chromosome 1, 215848385: 215848385
48 USH2A NM_206933.2(USH2A): c.14911C> T (p.Arg4971Ter) single nucleotide variant Pathogenic rs397517994 GRCh38 Chromosome 1, 215640615: 215640615
49 USH2A NM_206933.2(USH2A): c.10190_10191delAA (p.Lys3397Argfs) deletion Pathogenic rs397517964 GRCh37 Chromosome 1, 215960208: 215960209
50 USH2A NM_206933.2(USH2A): c.10190_10191delAA (p.Lys3397Argfs) deletion Pathogenic rs397517964 GRCh38 Chromosome 1, 215786866: 215786867

Expression for Usher Syndrome, Type Iia

Search GEO for disease gene expression data for Usher Syndrome, Type Iia.

Pathways for Usher Syndrome, Type Iia

Pathways related to Usher Syndrome, Type Iia according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.02 EGF GSK3B TGFB2

GO Terms for Usher Syndrome, Type Iia

Cellular components related to Usher Syndrome, Type Iia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 stereocilium GO:0032420 9.58 PDZD7 USH1C WHRN
2 photoreceptor inner segment GO:0001917 9.56 PDZD7 USH1C USH2A WHRN
3 stereocilium tip GO:0032426 9.5 PDZD7 USH1C WHRN
4 photoreceptor connecting cilium GO:0032391 9.46 PDZD7 USH1C USH2A WHRN
5 USH2 complex GO:1990696 9.37 PDZD7 USH2A
6 stereocilia ankle link GO:0002141 9.26 PDZD7 USH1C USH2A WHRN
7 stereocilia ankle link complex GO:0002142 8.92 PDZD7 USH1C USH2A WHRN

Biological processes related to Usher Syndrome, Type Iia according to GeneCards Suite gene sharing:

(show all 12)
# Name GO ID Score Top Affiliating Genes
1 visual perception GO:0007601 9.61 EYA4 RD3 USH2A
2 extrinsic apoptotic signaling pathway GO:0097191 9.51 GSK3B TGFB2
3 inner ear morphogenesis GO:0042472 9.5 PDZD7 USH1C WHRN
4 epithelial to mesenchymal transition GO:0001837 9.49 GSK3B TGFB2
5 establishment of protein localization GO:0045184 9.48 PDZD7 USH2A
6 photoreceptor cell maintenance GO:0045494 9.46 USH1C USH2A
7 inner ear receptor cell development GO:0060119 9.43 PDZD7 USH1C WHRN
8 inner ear receptor cell stereocilium organization GO:0060122 9.4 USH1C WHRN
9 auditory receptor cell stereocilium organization GO:0060088 9.37 PDZD7 WHRN
10 sensory perception of light stimulus GO:0050953 9.33 USH1C USH2A WHRN
11 inner ear auditory receptor cell differentiation GO:0042491 9.13 PDZD7 USH1C WHRN
12 sensory perception of sound GO:0007605 9.02 EYA4 PDZD7 USH1C USH2A WHRN

Molecular functions related to Usher Syndrome, Type Iia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein binding GO:0005515 9.4 EGF ESRRG EYA4 GSK3B HLX MAPRE2

Sources for Usher Syndrome, Type Iia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....